Trends of age-specific burden of gastric cancer in Taiwan by gender from 1990 to 2021. by Xiaohuang Yang (10182727)

Subjects:

Joinpoint Analysis of ASIR, ASPR, ASMR, and ASDR of gastric cancer in Taiwan, 1990–2021. by Xiaohuang Yang (10182727)

Subjects:

Difference scores for body dissatisfaction and self-esteem in each group. by Eriko Takahashi (22608061)

Subjects:

Gastric cancer cases and Age-Standardized Rates in Taiwan and the Chinese mainland for 1990 and 2021. by Xiaohuang Yang (10182727)

Subjects:

Overview of the experimental procedure and task instructions in Study 2. by Eriko Takahashi (22608061)

Subjects:

A path model of two-factor self-compassion. by Eriko Takahashi (22608061)

Subjects:

Comparison of the burden of gastric cancer by age in Taiwan between 1990 and 2021. by Xiaohuang Yang (10182727)

Subjects:

A path model of six-factor self-compassion. by Eriko Takahashi (22608061)

Subjects:

Summary of correlations regarding one- and two-factor self-compassion. by Eriko Takahashi (22608061)

Subjects:

Projections of Gastric Cancer Incidence and Mortality Burden in Taiwan Through 2036. by Xiaohuang Yang (10182727)

Subjects:

A path model of one-factor self-compassion. by Eriko Takahashi (22608061)

Subjects:

Sociodemographic characteristics of the participants. by Eriko Takahashi (22608061)

Subjects:

Flowchart of the screening process. by Huixia Ren (500186)

“…Efficacy was assessed through intraoperative outcomes, primary postoperative outcomes, and statistically significant postoperative outcomes. Patients with thyroid disorders undergoing TOTVA experienced longer overall operative time and hospital stays, reduced intraoperative blood loss, increased lymph node retrieval, higher incidence of infection, lower postoperative pain scores, reduced incidence of hypocalcemia, larger drainage volumes, and higher cosmetic effect scores compared with those undergoing.…”

Result of the AMSTAR-2 assessments. by Huixia Ren (500186)

“…Efficacy was assessed through intraoperative outcomes, primary postoperative outcomes, and statistically significant postoperative outcomes. Patients with thyroid disorders undergoing TOTVA experienced longer overall operative time and hospital stays, reduced intraoperative blood loss, increased lymph node retrieval, higher incidence of infection, lower postoperative pain scores, reduced incidence of hypocalcemia, larger drainage volumes, and higher cosmetic effect scores compared with those undergoing.…”

Characteristics of included reviews. by Huixia Ren (500186)

“…Efficacy was assessed through intraoperative outcomes, primary postoperative outcomes, and statistically significant postoperative outcomes. Patients with thyroid disorders undergoing TOTVA experienced longer overall operative time and hospital stays, reduced intraoperative blood loss, increased lymph node retrieval, higher incidence of infection, lower postoperative pain scores, reduced incidence of hypocalcemia, larger drainage volumes, and higher cosmetic effect scores compared with those undergoing.…”

Result of the PRISMA assessments. by Huixia Ren (500186)

“…Efficacy was assessed through intraoperative outcomes, primary postoperative outcomes, and statistically significant postoperative outcomes. Patients with thyroid disorders undergoing TOTVA experienced longer overall operative time and hospital stays, reduced intraoperative blood loss, increased lymph node retrieval, higher incidence of infection, lower postoperative pain scores, reduced incidence of hypocalcemia, larger drainage volumes, and higher cosmetic effect scores compared with those undergoing.…”

Result of the ROBIS assessments. by Huixia Ren (500186)

“…Efficacy was assessed through intraoperative outcomes, primary postoperative outcomes, and statistically significant postoperative outcomes. Patients with thyroid disorders undergoing TOTVA experienced longer overall operative time and hospital stays, reduced intraoperative blood loss, increased lymph node retrieval, higher incidence of infection, lower postoperative pain scores, reduced incidence of hypocalcemia, larger drainage volumes, and higher cosmetic effect scores compared with those undergoing.…”

Busulfan treatment induces orchitis. by Lingjun Zhao (21763122)

“…(C) interleukin (IL)-6, and (D) IL-1β; the concentrations for all factors significantly increase over time.</p>…”

Gender-specific incidence trends of HFMD in Guangzhou from 2013 to 2023. by Haipeng Luo (5322419)

Minimal data set. by Daan P. van den Brink (9900073)

“…Other markers of endothelial injury or inflammation were not significantly different between groups. No significant differences were observed in histologic injury scores and wet-to-dry ratios.…”